In a report released today, Chris O`Cull from Stifel Nicolaus maintained a Hold rating on Valvoline (VVV – Research Report), with a price ...

Barry Bannister, Stifel chief equity strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks for 2025.

Rhumbline Advisers trimmed its holdings in shares of Stifel Financial Corp. (NYSE:SF – Free Report) by 2.8% during the fourth ...

While the scope of U.S.-imposed tariffs continues to expand, their impact on the economy remains uncertain, according to economists Lindsey Piegza and Lauren Henderson of Stifel, Nicolaus & Co. in ...

ST. LOUIS, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.36 billion for the three months ended December 31, 2024, compared with $1.15 ...

DraftKings (NASDAQ:DKNG – Get Free Report) had its target price raised by equities research analysts at Stifel Nicolaus from ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

ST. LOUIS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced the launch of Stifel Discover, a new Stifel-branded content feed available through its Wealth ...

With Trevi poised to soon announce data from a trial of its Haduvio drug as a treatment for refractory chronic cough (RCC), ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...